OpenFi Secures €585k Pre-Seed Funding to Propel Expansion of Conversational AI Platform

OpenFi, a pioneering London-based conversational AI platform specializing in lead generation and customer nurture, has successfully closed a pre-seed funding round totaling €585k. The investment, spearheaded by Bijan Morvaridi and supported by Fortune Green Capital Ltd and Foundation Ventures Ltd, marks a significant milestone for the company as it accelerates plans for product enhancement and…

Read More

Predicta Biosciences Secures $5.2 Million Investment to Pave the Way in Blood Cancer Diagnostics

Predicta Biosciences, a pioneering precision oncology company, has announced a significant milestone with the successful closure of an oversubscribed $5.2 million seed funding round. Led by The Engine Ventures, this round saw participation from notable investors including Illumina Ventures, Time Boost Capital, the American Cancer Society Bright Edge, and the Oetgen family. The funds raised…

Read More

Eric Stonestrom Appointed as Board Chair of Cox Science Center and Aquarium

The Cox Science Center and Aquarium (CSCA) proudly announces the appointment of Eric Stonestrom as its new Board Chair, effective immediately following the retirement of Lew Crampton. Stonestrom, a distinguished technology executive with a deep-rooted passion for sciences, brings over 40 years of expertise in telecommunications to his new role. “Eric’s appointment marks an exciting…

Read More

Command Zero Revolutionizes Cyber Investigations with $21 Million Seed Funding

Command Zero, a pioneering force in cybersecurity, emerges from stealth mode today with a significant $21 million in seed funding led by Andreessen Horowitz, alongside Insight Partners and over 60 esteemed cyber industry leaders. This funding marks a pivotal moment for the industry’s first autonomous and user-led cyber investigation platform, aimed at resolving the critical…

Read More

RXO to Acquire Coyote Logistics from UPS, Cementing Position as a Leader in North American Transportation

In a strategic move to bolster its presence in the North American transportation sector, RXO (NYSE: RXO) has announced its definitive agreement to acquire Coyote Logistics from UPS for $1.025 billion in cash. This acquisition is set to propel RXO to the forefront as the third-largest provider of brokered transportation in the region, significantly enhancing…

Read More

Ethris GmbH: Leading the Charge in mRNA-Based Therapeutics with $5 Million Investment

Since its inception, Ethris GmbH has been a trailblazer in mRNA technology, revolutionizing the biotech landscape with its innovative approach to respiratory and cardiovascular diseases. Founded on a vision of harnessing messenger RNA (mRNA) for therapeutic breakthroughs, Ethris has consistently pushed boundaries, drawing attention from investors and global biotech leaders alike. Breakthroughs and Strategic Growth…

Read More

eAgronom Secures €10M Series A2 to Expand Sustainable Agriculture Initiatives

eAgronom, a pioneering climate tech company based in Tallinn, Estonia, has successfully closed a €10 million Series A2 equity round led by Swedbank. This funding milestone marks a significant leap forward for eAgronom, empowering the company to bolster its sustainable agriculture programs and expand its footprint across key global markets. The announcement was made through…

Read More

Oyster Secures $59M Series D Funding to Revolutionize Global Employment

Oyster®, the leading platform for global employment solutions, has successfully closed a $59 million Series D funding round. The financing, spearheaded by Silver Lake Waterman and supported by notable investors including Emergence Capital, Stripes, Georgian, G2 Venture Partners, and Endeavor Catalyst, positions Oyster to further accelerate its expansion and refine its innovative services. With this…

Read More

Vico Therapeutics Secures €65.8 Million in Series B Funding to Advance Groundbreaking Neurological Therapies

Vico Therapeutics, a pioneering clinical-stage genetic medicines company, has successfully closed its Series B funding round with a total investment of €65.8 million ($70.7 million). This financing round, led by Seroba and Kurma Partners, marks a significant milestone in Vico’s journey towards developing transformative therapies for severe neurological diseases. Vico Therapeutics specializes in antisense oligonucleotide…

Read More